The resulting PNEC conjugate, containing a nanozyme conjugated to a peptide that blocks PD-L1 via an MMP-2-sensitive linker, exhibits selective anti-tumor activity and the ability to promote transcellular transport of mtDNA and its uptake by dendritic cells. Here, CD274 is linked to neoplasm.